Literature DB >> 23835635

The Movement Disorders Society criteria for the diagnosis of Parkinson's disease dementia: their usefulness and limitations in elderly patients.

Michèle Kiesmann1, Jean-Baptiste Chanson, Julien Godet, Thomas Vogel, Laetitia Schweiger, Saïd Chayer, Georges Kaltenbach.   

Abstract

The aim of this study was to assess the performance of the Movement Disorders Society (MDS) criteria for the diagnosis of Parkinson's disease dementia (PDD) in the elderly, and also to evaluate the relevance of applying other tests in this patient population. The MDS criteria include a first short part in checklist form, and a second part which is used as a basis for reference and consists of an in-depth neuropsychological examination. Forty consecutive PD patients presenting with cognitive complaints were enrolled. An assessment was made of the performances of the MDS checklist compared with the MDS exhaustive cognitive examination which was used as a basis for reference, and with other cognitive tests including the Mattis Dementia Rating Scale (MDRS), the French version of the Grober and Buschke test, the verbal fluency test, the Rey-Osterreith complex figure and the paced auditory serial addition test. Out of a total of 40 PD subjects (mean age: 80.5 ± 4.9 years), 20 were diagnosed with PDD according to the checklist and 31 on the basis of the exhaustive examination, i.e. with 11 more patients diagnosed via the latter. The sensitivity of the checklist for the diagnosis of PDD was 0.64, with a specificity of 1.00. The use of the MDRS for PDD diagnosis with a cut-off at ≤ 120 showed a sensitivity of 0.80 and a specificity of 1.00, while at ≤ 132 it displayed a sensitivity of 1.00 and a specificity of 0.444. The specificity of the checklist for the diagnosis of PDD in the elderly was confirmed, but it was lacking in sensitivity. It was also found that the MDRS could be helpful in the diagnosis and screening of PDD.

Entities:  

Mesh:

Year:  2013        PMID: 23835635     DOI: 10.1007/s00415-013-7018-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

1.  Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.

Authors:  Peter Hobson; Jolyon Meara
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

2.  Validity of the 30-item geriatric depression scale in patients with Parkinson's disease.

Authors:  William M McDonald; Paul E Holtzheimer; Michael Haber; Jerrold L Vitek; Kimberly McWhorter; Mahlon Delong
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

3.  Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria.

Authors:  P Martinez-Martin; C Falup-Pecurariu; C Rodriguez-Blazquez; M Serrano-Dueñas; F J Carod Artal; J M Rojo Abuin; D Aarsland
Journal:  Parkinsonism Relat Disord       Date:  2011-06-30       Impact factor: 4.891

4.  Paced auditory serial-addition task: a measure of recovery from concussion.

Authors:  D M Gronwall
Journal:  Percept Mot Skills       Date:  1977-04

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 7.  The criterion validity of the Geriatric Depression Scale: a systematic review.

Authors:  J Wancata; R Alexandrowicz; B Marquart; M Weiss; F Friedrich
Journal:  Acta Psychiatr Scand       Date:  2006-12       Impact factor: 6.392

8.  A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force.

Authors:  M E Di Battista; P Giustini; S Bernardi; P Stirpe; N Vanacore; Giuseppe Meco
Journal:  J Neural Transm (Vienna)       Date:  2011-04-10       Impact factor: 3.575

9.  Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.

Authors:  Roberta Biundo; Luca Weis; Manuela Pilleri; Silvia Facchini; Patrizia Formento-Dojot; Annamaria Vallelunga; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2013-03-13       Impact factor: 3.575

10.  Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.

Authors:  Gisela Llebaria; Javier Pagonabarraga; Jaime Kulisevsky; Carmen García-Sánchez; Berta Pascual-Sedano; Alexandre Gironell; Mercè Martínez-Corral
Journal:  Mov Disord       Date:  2008-08-15       Impact factor: 10.338

View more
  7 in total

Review 1.  Neurological update: dementia.

Authors:  A J Larner
Journal:  J Neurol       Date:  2014-02-06       Impact factor: 4.849

Review 2.  Morphological basis of Parkinson disease-associated cognitive impairment: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-20       Impact factor: 3.850

3.  Multiculturalism: A Challenge for Cognitive Screeners in Parkinson's Disease.

Authors:  Marta Statucka; Kirsten Cherian; Alfonso Fasano; Renato P Munhoz; Melanie Cohn
Journal:  Mov Disord Clin Pract       Date:  2021-05-27

4.  Neuroimaging in Parkinson's disease dementia: connecting the dots.

Authors:  Rimona S Weil; Joey K Hsu; Ryan R Darby; Louis Soussand; Michael D Fox
Journal:  Brain Commun       Date:  2019-07-08

5.  Proteomics and bioinformatics approaches for the identification of plasma biomarkers to detect Parkinson's disease.

Authors:  Wenwen Dong; Chang Qiu; Dawei Gong; Xu Jiang; Wan Liu; Weiguo Liu; Li Zhang; Wenbin Zhang
Journal:  Exp Ther Med       Date:  2019-08-14       Impact factor: 2.447

6.  Comparison of Montreal cognitive assessment and Mattis dementia rating scale in the preoperative evaluation of subthalamic stimulation in Parkinson's disease.

Authors:  Eileen Gülke; Mohammad Alsalem; Maja Kirsten; Eik Vettorazzi; Chi-Un Choe; Ute Hidding; Simone Zittel-Dirks; Carsten Buhmann; Miriam Schaper; Alessandro Gulberti; Christian K E Moll; Wolfgang Hamel; Johannes Koeppen; Christian Gerloff; Monika Pötter-Nerger
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

7.  Validation of the Parkinson's Disease-Cognitive Rating Scale Applying the Movement Disorder Society Task Force Criteria for Dementia Associated with Parkinson's Disease.

Authors:  Marcos Serrano-Dueñas; Maite Serrano; Diana Villena; David Granda
Journal:  Mov Disord Clin Pract       Date:  2016-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.